Hydronephrosis and Hydroureter 

  • Author: Dennis G Lusaya, MD; Chief Editor: Bradley Fields Schwartz, DO, FACS   more...
 
Updated: Sep 20, 2011
 

Background

Hydronephrosis and hydroureter are common clinical conditions encountered not only by urologists but also by emergency medicine specialists and primary care physicians. Hydronephrosis is defined as distention of the renal calyces and pelvis with urine as a result of obstruction of the outflow of urine distal to the renal pelvis. Analogously, hydroureter is defined as a dilation of the ureter.

The presence of hydronephrosis or hydroureter can be physiologic or pathologic. It can be secondary to obstruction of the urinary tract, but it can also be present even without obstruction.

Obstructive uropathy refers to the functional or anatomic obstruction of urinary flow at any level of the urinary tract. Obstructive nephropathy is present when the obstruction causes functional or anatomic renal damage. Thus, the terms hydronephrosis and obstruction should not be used interchangeably.

The etiology and presentation of hydronephrosis and/or hydroureter in adults differ from that in neonates and children. Hydronephrosis/hydroureter caused by obstruction anywhere in the urinary tract may be acute or chronic, unilateral or bilateral. The major causes range from anatomic abnormalities (including urethral valves or stricture, and stenosis at the ureterovesical or ureteropelvic junction), which account for the majority of cases in children. In comparison, calculi are most common in young adults, while prostatic hypertrophy or carcinoma, retroperitoneal or pelvic neoplasms, and calculi are the primary causes in older patients.[1, 2]

Hydronephrosis or hydroureter is a normal finding in pregnant women. The renal pelvises and caliceal systems may be dilated as a result of progesterone effects and mechanical compression of the ureters at the pelvic brim. Dilatation of the ureters and renal pelvis is more prominent on the right side than the left side and is seen in up to 80% of pregnant women.[3] These changes can be visualized on ultrasound examination by the second trimester, and they may not resolve until 6-12 weeks postpartum.

Next

Pathophysiology

Hydronephrosis can result from anatomic or functional processes interrupting the flow of urine. This interruption can occur anywhere along the urinary tract from the kidneys to the urethral meatus. The rise in ureteral pressure leads to marked changes in glomerular filtration, tubular function, and renal blood flow. The glomerular filtration rate (GFR) declines significantly within hours following acute obstruction. This significant decline of GFR can persist for weeks after relief of obstruction. In addition, renal tubular ability to transport sodium, potassium, and protons and concentrate and to dilute the urine is severely impaired. The extent and persistence of these functional insults is directly related to the duration and extent of the obstruction. Brief disruptions are limited to reversible functional disturbance with little associated anatomic changes. More chronic disruptions lead to profound tubular atrophy and permanent nephron loss.

Increased ureteral pressure also results in pyelovenous and pyelolymphatic backflow. Gross changes within the urinary tract similarly depend on the duration, degree, and level of obstruction. Within the intrarenal collecting system, the degree of dilation is limited by surrounding renal parenchyma. However, the extrarenal components can dilate to the point of tortuosity.

To distinguish acute and chronic hydronephrosis, one may consider acute as hydronephrosis that, when corrected, allows full recovery of renal function. Conversely, chronic hydronephrosis is a situation in which the loss of function is irreversible even with correction of the obstruction. Early experiments with dogs showed that if acute unilateral obstruction is corrected within 2 weeks, full recovery of renal function is possible. However, after 6 weeks of obstruction, function is irreversibly lost.

Grossly, an acutely hydronephrotic system can be associated with little anatomic disturbance to renal parenchyma. On the other hand, a chronically dilated system may be associated with compression of the papillae, thinning of the parenchyma around the calyces, and coalescence of the septa between calyces. Eventually, cortical atrophy progresses to the point at which only a thin rim of parenchyma is present. Microscopic changes consist of dilation of the tubular lumen and flattening of the tubular epithelium. Fibrotic changes and increased collagen deposition are observed in the peritubular interstitium.

Previous
Next

Epidemiology

Frequency

United States

An autopsy series of 59,064 subjects ranging in age from neonates to geriatric persons reported hydronephrosis in 3.1%.[4] In this series, differences based on sex did not become apparent until age 20 years. At age 20-60 years, hydronephrosis was more common in women, which was suggested to be due to pregnancy and gynecologic malignancy. In men, prostatic diseases were indicated as the cause of the rise in prevalence after age 60 years. Autopsy studies also indicate that hydronephrosis is present in 2-2.5% of children.[4] The prevalence is slightly increased in boys, most of whom in the study were younger than 1 year.

These occurrence rates likely underestimate the prevalence because conditions such as temporary obstruction due to prior pregnancy or calculi were not included.

Mortality/Morbidity

Longstanding hydronephrosis may be associated with obstructive nephropathy and renal failure. Patients with complete or severe partial bilateral obstruction also may develop acute or chronic renal failure. In the latter setting, the patient is often asymptomatic and the urinalysis results may be relatively normal or reveal only a few white or red blood cells.[5] Thus, urinary tract obstruction should be considered in all patients with otherwise unexplained renal insufficiency. The history may be helpful in some cases, possibly revealing symptoms of prostatic enlargement or prior malignancy or renal calculi.

Urinary stasis may result in infection, renal scarring, calculus formation, and sepsis.

Hypertension is occasionally induced by obstruction. The mechanism responsible for the elevation in blood pressure varies with the duration and type of obstruction. What remains unclear, however, is that the factors described below result in hypertension in only a minority of obstructed patients:

  • Acute, unilateral obstruction can cause hypertension via activation of the renin-angiotensin system; renal vein renin studies lateralize the increase in renin secretion to the obstructed kidney, a finding similar to that in unilateral renal artery stenosis.[6]
  • Renin secretion is usually normal in patients with bilateral urinary tract obstruction or obstruction of a solitary functioning kidney.[6] In this condition, renal failure leading to volume expansion is typically present; the elevation in blood pressure is probably volume mediated and resolves with the diuresis following correction of the obstruction.
  • The plasma renin activity is also typically normal in chronic unilateral obstruction, and the presence of the contralateral healthy kidney prevents both renal failure and fluid retention.[6] Furthermore, relief of the obstruction may not correct the hypertension. These observations suggest that the kidney may have incurred some permanent damage and that the elevation in blood pressure is unrelated to the renal disease.

Sex

In women, gynecologic cancers and pregnancy are common causes. As such, among younger patients (aged 20-60 y), the frequency of hydronephrosis is higher in women than in men.

In men, obstruction secondary to prostatic hypertrophy and prostate cancer are the major causes of hydronephrosis. Consequently, among older patients (>60 y), the frequency of hydronephrosis is higher in men than in women.

Age

In young adults, calculi are the most common causes of hydroureter and hydronephrosis.

In children and in neonates, the relative frequency of the causes of antenatal hydronephrosis has been determined to be as follows:

  • Transient - 48%
  • Physiologic -15%
  • Ureteropelvic junction obstruction - 11%
  • Vesicoureteral reflux - 9%
  • Megaureter - 4%
  • Multicystic dysplastic kidney - 2%
  • Ureterocele - 2%
  • Posterior urethral valves - 1%
Previous
 
 
Contributor Information and Disclosures
Author

Dennis G Lusaya, MD  Associate Professor II, Department of Surgery (Urology), University of Santo Tomas; Head of Urology Unit, Benavides Cancer Institute, University of Santo Tomas Hospital; Chief of Urologic Oncology, St Luke's Medical Center Global City, Philippines

Dennis G Lusaya, MD is a member of the following medical societies: American Urological Association, Philippine College of Surgeons, Philippine Medical Association, Philippine Society of Urological Oncology, Philippine Urological Association, and Royal Australasian College of Surgeons

Disclosure: Nothing to disclose.

Coauthor(s)

Edgar V Lerma, MD, FACP, FASN, FAHA  Clinical Associate Professor of Medicine, Section of Nephrology, Department of Medicine, University of Illinois at Chicago College of Medicine; Research Director, Internal Medicine Training Program, Advocate Christ Medical Center; Consulting Staff, Associates in Nephrology, SC

Edgar V Lerma, MD, FACP, FASN, FAHA is a member of the following medical societies: American Heart Association, American Medical Association, American Society of Hypertension, American Society of Nephrology, Chicago Medical Society, Illinois State Medical Society, National Kidney Foundation, and Society of General Internal Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Richard A Santucci, MD, FACS  Specialist-in-Chief, Department of Urology, Detroit Medical Center; Chief of Urology, Detroit Receiving Hospital; Director, The Center for Urologic Reconstruction; Clinical Professor of Urology, Michigan State University College of Medicine

Richard A Santucci, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, and Société Internationale d'Urologie (International Society of Urology)

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

J Stuart Wolf Jr, MD, FACS  The David A Bloom Professor of Urology, Director, Division of Endourology and Stone Disease, Department of Urology, University of Michigan Medical School

J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology

Disclosure: Nothing to disclose.

Chief Editor

Bradley Fields Schwartz, DO, FACS  Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine

Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Srinivas Vourganti, MD, Prakash Maniam, MD, and martin I Resnick, MD, to the development and writing of this article.

References
  1. Rose BD, Black RM. Manual of Clinical Problems in Nephrology. Boston, Mass: Little, Brown & Co; 1988:337-343.

  2. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. Jan 29-Feb 4 2005;365(9457):417-30. [Medline].

  3. Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol. Mar 1988;27(3):249-59. [Medline].

  4. Pain VM, Strandhoy JW, Assimis, DG. Pathophysiology of urinary tract obstruction. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein AJ, eds. Campbell-Walsh Urology. Vol 2. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2007:1227-73.

  5. Weidmann P, Beretta-Piccoli C, Hirsch D, Reubi FC, Massry SG. Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Intern Med. Oct 1977;87(4):437-40. [Medline].

  6. Vaughan ED Jr, Bühler FR, Laragh JH. Normal renin secretion in hypertensive patients with primarily unilateral chronic hydronephrosis. J Urol. Aug 1974;112(2):153-6. [Medline].

  7. Josephson S. Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management. BJU Int. May 2000;85(7):973. [Medline].

  8. Platt JF, Rubin JM, Ellis JH. Acute renal obstruction: evaluation with intrarenal duplex Doppler and conventional US. Radiology. Mar 1993;186(3):685-8. [Medline].

  9. Demko TM, Diamond JR, Groff J. Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. J Am Soc Nephrol. Apr 1997;8(4):684-8. [Medline].

  10. Klahr S. Pathophysiology of obstructive nephropathy. Kidney Int. Feb 1983;23(2):414-26. [Medline].

  11. Webb JA. Ultrasonography in the diagnosis of renal obstruction. BMJ. Oct 27 1990;301(6758):944-6. [Medline]. [Full Text].

  12. Thoeny HC, Binser T, Roth B, Kessler TM, Vermathen P. Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study. Radiology. Sep 2009;252(3):721-8. [Medline].

  13. Lupton EW, Testa HJ. The obstructive diuresis renogram: an appraisal of the significance. J Urol. Apr 1992;147(4):981-3. [Medline].

  14. Persutte WH, Hussey M, Chyu J, Hobbins JC. Striking findings concerning the variability in the measurement of the fetal renal collecting system. Ultrasound Obstet Gynecol. Mar 2000;15(3):186-90. [Medline].

  15. Robinson JN, Tice K, Kolm P, Abuhamad AZ. Effect of maternal hydration on fetal renal pyelectasis. Obstet Gynecol. Jul 1998;92(1):137-41. [Medline].

  16. Woodward M, Frank D. Postnatal management of antenatal hydronephrosis. BJU Int. Jan 2002;89(2):149-56. [Medline].

  17. Chung S, Majd M, Rushton HG, Belman AB. Diuretic renography in the evaluation of neonatal hydronephrosis: is it reliable?. J Urol. Aug 1993;150(2 Pt 2):765-8. [Medline].

  18. Taylor A Jr, Clark S, Ball T. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates. Clin Nucl Med. Jul 1994;19(7):575-80. [Medline].

  19. Gordon I. Diuretic renography in infants with prenatal unilateral hydronephrosis: an explanation for the controversy about poor drainage. BJU Int. Apr 2001;87(6):551-5. [Medline].

  20. Koff SA. Postnatal management of antenatal hydronephrosis using an observational approach. Urology. May 2000;55(5):609-11. [Medline].

  21. Gordon I, Dhillon HK, Gatanash H, Peters AM. Antenatal diagnosis of pelvic hydronephrosis: assessment of renal function and drainage as a guide to management. J Nucl Med. Sep 1991;32(9):1649-54. [Medline].

  22. Kim DY, Mickelson JJ, Helfand BT, Maizels M, Kaplan WE, Yerkes EB. Fetal pyelectasis as predictor of decreased differential renal function. J Urol. Oct 2009;182(4 Suppl):1849-53. [Medline].

  23. de Bruyn R, Marks SD. Postnatal investigation of fetal renal disease. Semin Fetal Neonatal Med. Jun 2008;13(3):133-41. [Medline].

  24. Grattan-Smith JD, Little SB, Jones RA. MR urography evaluation of obstructive uropathy. Pediatr Radiol. Jan 2008;38 Suppl 1:S49-69. [Medline].

  25. Mamì C, Paolata A, Palmara A, et al. Outcome and management of isolated moderate renal pelvis dilatation detected at postnatal screening. Pediatr Nephrol. Oct 2009;24(10):2005-8. [Medline].

  26. Dacher JN, Mandell J, Lebowitz RL. Urinary tract infection in infants in spite of prenatal diagnosis of hydronephrosis. Pediatr Radiol. 1992;22(6):401-4; discussion 404-5. [Medline].

  27. Walsh TJ, Hsieh S, Grady R, Mueller BA. Antenatal hydronephrosis and the risk of pyelonephritis hospitalization during the first year of life. Urology. May 2007;69(5):970-4. [Medline].

  28. Coelho GM, Bouzada MC, Lemos GS, Pereira AK, Lima BP, Oliveira EA. Risk factors for urinary tract infection in children with prenatal renal pelvic dilatation. J Urol. Jan 2008;179(1):284-9. [Medline].

  29. Estrada CR, Peters CA, Retik AB, Nguyen HT. Vesicoureteral reflux and urinary tract infection in children with a history of prenatal hydronephrosis--should voiding cystourethrography be performed in cases of postnatally persistent grade II hydronephrosis?. J Urol. Feb 2009;181(2):801-6; discussion 806-7. [Medline].

  30. Lidefelt KJ, Herthelius M. Antenatal hydronephrosis: infants with minor postnatal dilatation do not need prophylaxis. Pediatr Nephrol. Nov 2008;23(11):2021-4. [Medline].

  31. Coplen DE. Prenatal intervention for hydronephrosis. J Urol. Jun 1997;157(6):2270-7. [Medline].

  32. Kilby M, Khan K, Morris K, et al. PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG. Jul 2007;114(7):904-5, e1-4. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.